Rigel Pharmaceuticals Inc (RIGL) — Cash Flow Quality Index
Rigel Pharmaceuticals Inc (RIGL) has a Cash Flow Quality Index of 0.31x as of March 2026. Operating cash flow of $2.73 Million is below net income of $8.65 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Rigel Pharmaceuticals Inc (RIGL) cash conversion ratio to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Rigel Pharmaceuticals Inc Cash Flow Quality Index (2010–2025)
Historical Cash Flow Quality Index for Rigel Pharmaceuticals Inc across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Rigel Pharmaceuticals Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Rigel Pharmaceuticals Inc (2010–2025)
Year-by-year earnings quality comparison for Rigel Pharmaceuticals Inc. For live market cap and the full company financial profile, see Rigel Pharmaceuticals Inc stock valuation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.21x | $75.66 Million | $367.02 Million | ▼ -88.5% |
| 2024 | 1.80x | $31.47 Million | $17.48 Million | ▲ +45.9% |
| 2010 | 1.23x | $46.74 Million | $37.89 Million | — |